Allogene Therapeutics
ALLO
#8751
Rank
ยฃ0.16 B
Marketcap
ยฃ0.48
Share price
-5.88%
Change (1 day)
-48.92%
Change (1 year)

EPS for Allogene Therapeutics (ALLO)

EPS in 2026 (TTM): -ยฃ0.50

According to Allogene Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ0.51. In 2025 the company made an earnings per share (EPS) of -ยฃ0.67 an increase over its 2024 EPS that were of -ยฃ1.02.

EPS history for Allogene Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.50-24.58%
2025-ยฃ0.67-34.59%
2024-ยฃ1.02
2022-ยฃ1.7722.75%
2021-ยฃ1.44-9.13%
2020-ยฃ1.5914.92%
2019-ยฃ1.38-9.42%
2018-ยฃ1.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ1.03 101.49%๐Ÿ‡บ๐Ÿ‡ธ USA